174
Participants
Start Date
November 29, 2022
Primary Completion Date
June 5, 2024
Study Completion Date
July 9, 2024
SAGE-718
Softgel lipid capsules.
SAGE-718-matching Placebo
Softgel lipid capsules.
Sage Investigational Site, Staten Island
Sage Investigational Site, Brooklyn
Sage Investigational Site, Buffalo
Sage Investigational Site, Abington
Sage Investigational Site, Fairfax
Sage Investigational Site, Raleigh
Sage Investigational Site, Decatur
Sage Investigational Site, Savannah
Sage Investigational Site, Jacksonville
Sage Investigational Site, Pensacola
Sage Investigational Site, Winter Park
Sage Investigational Site, Hollywood
Sage Investigational Site, Miami
Sage Investigational Site, Palm Beach Gardens
Sage Investigational Site, Tampa
Sage Investigational Site, Nashville
Sage Investigational Site, Memphis
Sage Investigational Site, Chicago
Sage Investigational Site, Chesterfield
Sage Investigational Site, Papillion
Sage Investigational Site, Dallas
Sage Investigational Site, Houston
Sage Investigational Site, Austin
Sage Investigational Site, Englewood
Sage Investigational Site, Meridian
Sage Investigational Site, Gilbert
Sage Investigational Site, Phoenix
Sage Investigational Site, Albuquerque
Sage Investigational Site, Long Beach
Sage Investigational Site, Sherman Oaks
Sage Investigational Site, San Diego
Sage Investigational Site, Redlands
Sage Investigational Site, Lafayette
Sage Investigational Site, Honolulu
Sage Investigational Site, Charlestown
Sage Investigational Site, Methuen
Sage Investigational Site, Toms River
Sage Investigational Site, Bayamón
Sage Investigational Site, Rio Piedras
Supernus Pharmaceuticals, Inc.
INDUSTRY